These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2122546)

  • 21. Distribution and clinical significance of lupus anticoagulant and anticardiolipin antibody in 349 patients with systemic lupus erythematosus.
    Ninomiya C; Taniguchi O; Kato T; Hirano T; Hashimoto H; Hirose S
    Intern Med; 1992 Feb; 31(2):194-9. PubMed ID: 1600266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases.
    Gastineau DA; Kazmier FJ; Nichols WL; Bowie EJ
    Am J Hematol; 1985 Jul; 19(3):265-75. PubMed ID: 3925759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus.
    Martini F; Farsi A; Gori AM; Boddi M; Fedi S; Domeneghetti MP; Passaleva A; Prisco D; Abbate R
    Lupus; 1996 Jun; 5(3):206-11. PubMed ID: 8803891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy.
    Pattison NS; McKay EJ; Liggins GC; Lubbe WF
    N Z Med J; 1987 Feb; 100(817):61-4. PubMed ID: 3103033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus.
    Viard JP; Amoura Z; Bach JF
    Am J Med; 1992 Aug; 93(2):181-6. PubMed ID: 1497015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus.
    Wong KL; Liu HW; Ho K; Chan K; Wong R
    J Rheumatol; 1991 Aug; 18(8):1187-92. PubMed ID: 1941822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.
    Derksen RH; Hasselaar P; Blokzijl L; Gmelig Meyling FH; De Groot PG
    Ann Rheum Dis; 1988 May; 47(5):364-71. PubMed ID: 3133992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant.
    Nojima J; Suehisa E; Akita N; Toku M; Fushimi R; Tada H; Kuratsune H; Machii T; Kitani T; Amino N
    Br J Haematol; 1997 Mar; 96(3):447-50. PubMed ID: 9054646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population.
    Lockwood CJ; Romero R; Feinberg RF; Clyne LP; Coster B; Hobbins JC
    Am J Obstet Gynecol; 1989 Aug; 161(2):369-73. PubMed ID: 2504043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines.
    Swadzba J; Iwaniec T; Pulka M; De Laat B; De Groot PG; Musial J
    J Thromb Haemost; 2011 Sep; 9(9):1776-83. PubMed ID: 21707912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiphospholipid antibodies in systemic lupus erythematosus: incidence, significance and relation to lupus nephritis].
    Zea Mendoza A; Rodríguez García A; Irigoyen Oyarzábal MV; Vázquez Díaz M; Pardo Vigo A; Mampaso FM; Ortuño Mirete J
    Med Clin (Barc); 1989 May; 92(19):724-8. PubMed ID: 2502695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased factor VIIa levels in systemic lupus erythematosus patients with lupus anticoagulant.
    Matsuda J; Gohchi K; Kawasugi K
    Int J Hematol; 1997 Feb; 65(2):143-9. PubMed ID: 9071818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus.
    Ishii Y; Nagasawa K; Mayumi T; Niho Y
    Ann Rheum Dis; 1990 Jun; 49(6):387-90. PubMed ID: 2383061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of thrombocytopenia in SLE patients with a high level of anticardiolipin antibodies combined with lupus anticoagulant.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Toku M; Tada H; Yamaguti K; Koike T; Kanakura Y; Kitani T; Amino N
    Am J Hematol; 1998 May; 58(1):55-60. PubMed ID: 9590150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin.
    Rote NS; Dostal-Johnson D; Branch DW
    Am J Obstet Gynecol; 1990 Aug; 163(2):575-84. PubMed ID: 2117391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for thrombosis in lupus patients.
    Hasselaar P; Derksen RH; Blokzijl L; Hessing M; Nieuwenhuis HK; Bouma BN; De Groot PG
    Ann Rheum Dis; 1989 Nov; 48(11):933-40. PubMed ID: 2512863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.